Chargement en cours...
Treatment with the phosphodiesterase type 4 inhibitor rolipram fails to inhibit blood brain barrier disruption in MS
Rolipram, a prototypic phosphodiesterase-4 inhibitor is highly effective in suppressing Th1 autoimmunity in multiple animal models, including experimental autoimmune encephalomyelitis (EAE). Additionally, Rolipram has been extensively studied as a potential neuroprotective agent. Based on its anti-i...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3085182/ https://ncbi.nlm.nih.gov/pubmed/19776093 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458509345903 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|